← Health and Human Services (NIH, ARPA-H, CDC…)
Development of an annual test to inform women about their future fertility
In short: Development of an annual test to inform women about their future fertility - The purpose of this topic is to discover new biomarkers that provide women with actionable data for fertility planning.
Excerpt from the official topic description. Read the full solicitation before deciding to apply.
| Agency | Health and Human Services (NIH, ARPA-H, CDC…) · ARPA-H |
|---|---|
| Program | — |
| Phase | BOTH, BOTH |
| Topic number | ARPA-H 01 |
| Solicitation | 7599226SN106 |
| Release date | Jun 11, 2026 |
| Open date | Jun 11, 2026 |
| Close date | Sep 30, 2027 |
| Status on SBIR.gov | Open |
View official solicitation SBIR.gov topic page
Full description (from SBIR.gov)
Development of an annual test to inform women about their future fertility - The purpose of this topic is to discover new biomarkers that provide women with actionable data for fertility planning. Results from this work will help inform the program manager regarding the feasibility of future programs focused on enhancing natural fertility before the need of IVF and guiding the development of women’s health monitoring and improvement tools. This work will develop a diagnostic test that can assess fertility status and generate an estimated timeline for the onset of infertility. This topic seeks to develop a test that is affordable, suitable for at least annual use, and provides user-friendly results for patients and care teams to support childbearing decisions.
Possibly related past awards
- Development of an electrical impedance myography (EIM) vaginal device for the evaluation of pelvic skeletal muscles by BOLD TYPE LLC (Phase I, 2023, $384,558)
- Augmented Reality Personalized Motion Tracking Assessment and Improvement Technology for Fall Prevention for the Spanish Speaking Hispanic/Latino Population in a Community Setting Using Mobile Phone by KINIMA, INC. (Phase I, 2023, $259,964)
- Fast-Track Multimodal monitoring for neonatal neurocritical care by MEDITRACE LLC (Phase I, 2023, $260,434)
Matched by keyword overlap within the same agency from the SBIR.gov public award dataset. Not an official linkage.
SBIR Radar Pro · Get an email the morning a new topic matches your keywords, plus a personal deadline calendar and CSV export. See Pro ($19/mo, founding price) → or set up free beta alerts.
Get new SBIR/STTR topics every week
New topics, plus everything closing in the next 14 days. Free, one email a week.